These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 29874997)

  • 21. Alox15/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis.
    Cai W; Liu L; Shi X; Liu Y; Wang J; Fang X; Chen Z; Ai D; Zhu Y; Zhang X
    Circulation; 2023 May; 147(19):1444-1460. PubMed ID: 36987924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ferroptosis in myocardial ischemia/reperfusion model of rat and its association with Sestrin 1.
    Yang F; Wang W; Zhang Y; Nong J; Zhang L
    Adv Clin Exp Med; 2023 Feb; 32(2):219-231. PubMed ID: 36413176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Non-Transferrin-Bound Iron in the pathogenesis of cardiotoxicity in patients with ST-elevation myocardial infarction assessed by Cardiac Magnetic Resonance Imaging.
    Roghi A; Poggiali E; Duca L; Mafrici A; Pedrotti P; Paccagnini S; Brenna S; Galli A; Consonni D; Cappellini MD
    Int J Cardiol; 2015 Nov; 199():326-32. PubMed ID: 26241638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Ferroptosis in Adverse Left Ventricular Remodeling Following Acute Myocardial Infarction.
    Komai K; Kawasaki NK; Higa JK; Matsui T
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Necroptosis mediated by impaired autophagy flux contributes to adverse ventricular remodeling after myocardial infarction.
    Zhang H; Yin Y; Liu Y; Zou G; Huang H; Qian P; Zhang G; Zhang J
    Biochem Pharmacol; 2020 May; 175():113915. PubMed ID: 32179044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent Iron Within the Infarct Core After ST-Segment Elevation Myocardial Infarction: Implications for Left Ventricular Remodeling and Health Outcomes.
    Carberry J; Carrick D; Haig C; Ahmed N; Mordi I; McEntegart M; Petrie MC; Eteiba H; Hood S; Watkins S; Lindsay M; Davie A; Mahrous A; Ford I; Sattar N; Welsh P; Radjenovic A; Oldroyd KG; Berry C
    JACC Cardiovasc Imaging; 2018 Sep; 11(9):1248-1256. PubMed ID: 29153575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiomyocyte Damage: Ferroptosis Relation to Ischemia-Reperfusion Injury and Future Treatment Options.
    Laukaitiene J; Gujyte G; Kadusevicius E
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
    Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
    Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifaceted role of ferroptosis in cardiovascular disease.
    Li C; Zhu X; Chen J; Xie X; Liang S; Liu X; Gong Q; Guo J
    Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(2):183-193. PubMed ID: 36815377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced research on the regulated necrosis mechanism in myocardial ischemia-reperfusion injury.
    Deng J
    Int J Cardiol; 2021 Jul; 334():97-101. PubMed ID: 33930510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue Resident CCR2- and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury.
    Bajpai G; Bredemeyer A; Li W; Zaitsev K; Koenig AL; Lokshina I; Mohan J; Ivey B; Hsiao HM; Weinheimer C; Kovacs A; Epelman S; Artyomov M; Kreisel D; Lavine KJ
    Circ Res; 2019 Jan; 124(2):263-278. PubMed ID: 30582448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment-Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling.
    Bulluck H; Rosmini S; Abdel-Gadir A; White SK; Bhuva AN; Treibel TA; Fontana M; Ramlall M; Hamarneh A; Sirker A; Herrey AS; Manisty C; Yellon DM; Kellman P; Moon JC; Hausenloy DJ
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):e004940. PubMed ID: 27894068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Broadening horizons: The role of ferroptosis in myocardial ischemia-reperfusion injury.
    Zhao K; Chen X; Bian Y; Zhou Z; Wei X; Zhang J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2269-2286. PubMed ID: 37119287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular mechanisms of ferroptosis and its role in cardiovascular disease.
    Zhang Y; Xin L; Xiang M; Shang C; Wang Y; Wang Y; Cui X; Lu Y
    Biomed Pharmacother; 2022 Jan; 145():112423. PubMed ID: 34800783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-elicited cardiac microvascular endothelial cell-derived exosomal miR-210-3p alleviate hypoxia/reoxygenation-induced myocardial cell injury through inhibiting transferrin receptor 1-mediated ferroptosis.
    Lei D; Li B; Isa Z; Ma X; Zhang B
    Tissue Cell; 2022 Dec; 79():101956. PubMed ID: 36272206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Insight Into the Fate of Cardiomyocytes in Ischemia-Reperfusion Injury: From Iron Metabolism to Ferroptosis.
    Li JY; Liu SQ; Yao RQ; Tian YP; Yao YM
    Front Cell Dev Biol; 2021; 9():799499. PubMed ID: 34926476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases.
    Chen Y; Li X; Wang S; Miao R; Zhong J
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart.
    Wu X; Sagave J; Rutkovskiy A; Haugen F; Baysa A; Nygård S; Czibik G; Dahl CP; Gullestad L; Vaage J; Valen G
    Life Sci; 2014 Mar; 97(2):145-54. PubMed ID: 24398041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferroptosis: Opportunities and Challenges in Myocardial Ischemia-Reperfusion Injury.
    Zhao WK; Zhou Y; Xu TT; Wu Q
    Oxid Med Cell Longev; 2021; 2021():9929687. PubMed ID: 34725566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.